For citations:
Pronin A.V., Cheknev S.B., Nikolaeva T.N., Kozlov V.V., Kozhevnikova T.N., Vostrova E.I., Grigorieva E.A., Sosnovskaya O.Yu., Sarycheva M.A., Vostrov A.V., Narovlyansky A.N., Sanin A.V. Immunobiological efficacy of a new sodium polyprenyl phosphate based medicine for the treatment and prevention of experimenrtal metabolic syndrome. Medical Immunology (Russia). 2024;26(5):1061-1070. (In Russ.) https://doi.org/10.15789/1563-0625-IEO-16729
Email this article 